A Second Open-Label Extension of a Double-Blind, Parallel, Phase IV Study to Assess the Efficacy and Safety of Adjunctive Lovaza (Formerly Known as Omacor) Therapy in Hypertriglyceridemic Subjects Treated With Antara.
Latest Information Update: 17 Jul 2023
At a glance
- Drugs Fenofibrate (Primary) ; Omega-3-acid ethyl esters (Primary)
- Indications Hypertriglyceridaemia
- Focus Biomarker; Therapeutic Use
- Sponsors GlaxoSmithKline; GSK; Reliant Pharmaceuticals
- 09 Jun 2009 Planned end date changed from 1 Feb 2007 to 1 Mar 2007 as reported by ClinicalTrials.gov.(NCT00246636).
- 09 Jun 2009 Planned end date changed from 1 Feb 2007 to 1 Mar 2007 as reported by ClinicalTrials.gov.(NCT00246636).
- 06 May 2008 Status changed from in progress to completed as reported by ClinicialTrials.gov.